Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AmBisome + Isavuconazole vs AmBisome in Pulmonary Mucormycosis
NCT06756191Phase 4Not yet recruiting
- Start
- Jan 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of isavuconazole in mucormycosis. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
isavuconazole
03
Conditions
mucormycosis
Beyond the preview
Go deeper on NCT06756191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06756191.